ScholarIQanswers from OpenAlex & ORCID
G. Kees Hovingh
ResearcherPublications, citations & collaboration network
G. Kees Hovingh is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does G. Kees Hovingh have?
ScholarIQindexed works
G. Kees Hovingh has 336 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does G. Kees Hovingh have?
ScholarIQcitation count
G. Kees Hovingh has 33,163 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of G. Kees Hovingh?
ScholarIQh-index
G. Kees Hovingh has an h-index of 76 in OpenAlex.
What is the i10-index of G. Kees Hovingh?
ScholarIQi10-index
G. Kees Hovingh has an i10-index of 208 in OpenAlex.
What is the ORCID of G. Kees Hovingh?
ScholarIQorcid
The ORCID for G. Kees Hovingh is on the source record.
What is the OpenAlex record for G. Kees Hovingh?
ScholarIQopenalex
The OpenAlex for G. Kees Hovingh is on the source record.
What are the most-cited papers on G. Kees Hovingh?
ScholarIQmost cited works
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
A. Michael Lincoff, Kirstine Brown‐Frandsen, Helen M. Colhoun, John Deanfield, Scott S. Emerson, Sille Esbjerg, Søren Hardt‐Lindberg, G. Kees Hovingh, Steven E. Kahn, Robert F. Kushner, Ildiko Lingvay, Tuğçe Kalaycı Oral, Marie Mide Michelsen, Jorge Plutzky, Christoffer W. Tornøe, Donna H. Ryan
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
Mikhail Kosiborod, Steen Z. Abildstrøm, Barry A. Borlaug, Javed Butler, Søren Rasmussen, Melanie J. Davies, G. Kees Hovingh, Dalane W. Kitzman, Marie L.S. Lindegaard, Daniél V. Møller, Sanjiv J. Shah, Marianne Bach Treppendahl, Subodh Verma, Walter P. Abhayaratna, Fozia Ahmed, Vijay Chopra, Justin A. Ezekowitz, Michael Fu, Hiroshi Ito, Małgorzata Lelonek, Vojtěch Melenovský, Béla Merkely, Julio Núñez, Eduardo Perna, Morten Schou, Michele Senni, Kavita Sharma, Peter van der Meer, Dirk von Lewinski, Dennis Wolf, Mark C. Petrie
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
Erik S.G. Stroes, Paul D. Thompson, Alberto Corsini, Georgirene D. Vladutiu, Frederick J. Raal, Kausik K. Ray, Michael Roden, Evan A. Stein, Lâle Tokgözoğlu, Børge G. Nordestgaard, Éric Bruckert, Guy De Backer, Ronald M. Krauss, Ulrich Laufs, Raúl D. Santos, Robert A. Hegele, G. Kees Hovingh, Lawrence A. Leiter, François Mach, Winfried März, Connie B. Newman, Olov Wiklund, Terry A. Jacobson, Alberico L. Catapano, M. John Chapman, Henry N. Ginsberg, European Atherosclerosis Society Consensus Panel, Erik S.G. Stroes, Paul D. Thompson, Alberto Corsini, Georgirene D. Vladutiu, Frederick J. Raal, Kausik K. Ray, Michael Roden, Evan A. Stein, Lâle Tokgözoğlu, Børge G. Nordestgaard, Eric Bruckert, Ronald M. Krauss, Ulrich Laufs, Raul D. Santos, Winfried März, Connie B. Newman, M. John Chapman, Henry N. Ginsberg, M. John Chapman, Henry N. Ginsberg, Guy De Backer, Alberico L. Catapano, Robert A. Hegele, G. Kees Hovingh, Terry A. Jacobson, Lawrence A. Leiter, François Mach, Olov Wiklund
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
M. Cuchel, Éric Bruckert, H. N. Ginsberg, F. J. Raal, R. D. Santos, Robert A. Hegele, Jan Albert Kuivenhoven, Børge G. Nordestgaard, Olivier Descamps, E. Steinhagen-Thiessen, Anne Tybjærg‐Hansen, Gerald F. Watts, Maurizio Averna, Cathérine Boileau, Jan Borén, Alberico L. Catapano, Joep C. Defesche, G. Kees Hovingh, Steve E. Humphries, Petri T. Kovanen, L. Masana, P. Pajukanta, Klaus G. Parhofer, Kausik K. Ray, Anton F. H. Stalenhoef, Erik S.G. Stroes, Marja‐Riitta Taskinen, Albert Wiegman, Olov Wiklund, M. John Chapman, for the European Atherosclerosis Society Consensus Panel on Familial Hypercholesterolaemia, M. Cuchel, Éric Bruckert, M. John Chapman, O. S. Descamps, H. N. Ginsberg, Robert A. Hegele, Jan Albert Kuivenhoven, B. G. Nordestgaard, F. J. Raal, R. D. Santos, E. Steinhagen-Thiessen, Anne Tybjærg‐Hansen, Gerald F. Watts, M. John Chapman, Henry N. Ginsberg, Maurizio Averna, Cathérine Boileau, J. Boren, Alberico L. Catapano, Joep C. Defesche, G. K. Hovingh, Steve E. Humphries, Petri T. Kovanen, L. Masana, P. Pajukanta, Klaus G. Parhofer, Kausik K. Ray, Anton F. H. Stalenhoef, Erik S.G. Stroes, Marja‐Riitta Taskinen, Albert Wiegman, Olov Wiklund
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
Paul M. Ridker, Matt Devalaraja, Florian M.M. Baeres, Mads D.M. Engelmann, G. Kees Hovingh, Milana Ivkovic, Larry Lo, Douglas Kling, Pablo E. Pérgola, Dominic S. Raj, Peter Libby, Michael Davidson